secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2026-09-23T20:05:49+00:00
Accession:  0001522767-26-000188
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed files proxy for Oct 28 special meeting to approve 1-for-50 to 1-for-100 reverse split
--------------------------------------------------------------------------------

- Special meeting set for Oct 28, 2026 at 9:30 am ET; record date Sept 4, 2026 for voting.
- Board authorized to execute reverse split at ratio between 1-for-50 and 1-for-100, at its discretion.
- Purpose: meet minimum share price requirements for potential listing on U.S. national exchange.
- No fractional shares; cash payment for fractional interests if split implemented.
- CEO Jon Levine: listing on major exchange could broaden investor base and improve capital markets access.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276726000188/0001522767-26-000188-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276726000188/mrmd-20260923.htm
  HTML page:      https://secwatch.observer/filing/0001522767-26-000188

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer